The purpose of this study is to assess the impact of suvorexant on established measures of
smoking relapse risk (craving,withdrawal, stress reactivity, latency to self-administration)
and to validate the somnolent effect of suvorexant on sleep metrics in a sample of
individuals with tobacco use disorder
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston